Personalized medicine. New cystic fibrosis drug offers hope, at a price.
Jocelyn
J
Kaiser
D000627:Aminophenols / Q000191:economics / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000235:genetics*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D017277:Drug Approval; D016527:Drug Costs; D006801:Humans; D058990:Molecular Targeted Therapy; D009154:Mutation; D057285:Precision Medicine; D015363:Quinolones / Q000191:economics / Q000627:therapeutic use*; D054852:Small Molecule Libraries; D014481:United States; D014486:United States Food and Drug Administration
D000627:Aminophenols; C505032:CFTR protein, human; D015363:Quinolones; D054852:Small Molecule Libraries; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C545203:ivacaftor